300573 Stock Overview
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Shenyang Xingqi Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥80.30 |
| 52 Week High | CN¥214.36 |
| 52 Week Low | CN¥64.88 |
| Beta | 0.10 |
| 11 Month Change | -18.78% |
| 3 Month Change | -16.69% |
| 1 Year Change | -23.67% |
| 33 Year Change | 30.43% |
| 5 Year Change | n/a |
| Change since IPO | 14.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300573 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -8.2% | -1.5% | -2.1% |
| 1Y | -23.7% | -9.4% | 2.8% |
Return vs Industry: 300573 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 300573 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 300573 volatility | |
|---|---|
| 300573 Average Weekly Movement | 13.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300573's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300573's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | 1,995 | E. Gao | www.sinqi.com |
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company offers corneal, anti-bacteria, artificial tears, anti-inflammation, anti-allergic, mydriactics, anti-fatigue, and dry eye treatment products.
Shenyang Xingqi Pharmaceutical Co.,Ltd. Fundamentals Summary
| 300573 fundamental statistics | |
|---|---|
| Market cap | CN¥14.07b |
| Earnings (TTM) | CN¥348.47m |
| Revenue (TTM) | CN¥1.80b |
40.4x
P/E Ratio7.8x
P/S RatioIs 300573 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300573 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.80b |
| Cost of Revenue | CN¥403.79m |
| Gross Profit | CN¥1.40b |
| Other Expenses | CN¥1.05b |
| Earnings | CN¥348.47m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.99 |
| Gross Margin | 77.59% |
| Net Profit Margin | 19.34% |
| Debt/Equity Ratio | 14.1% |
How did 300573 perform over the long term?
See historical performance and comparison